Ayaka Takeda - Search Results

Year	Number of Results
2006	1
2018	1
2021	4
2022	3
2023	1
2024	0

1

Serum IgE reduction and paradoxical eosinophilia associated with allergic conjunctivitis after dupilumab therapy.

Kimura A, Takeda A, Ikebukuro T, Hori J. Kimura A, et al. Among authors: takeda a. J Ophthalmic Inflamm Infect. 2021 Feb 15;11(1):3. doi: 10.1186/s12348-020-00234-y. J Ophthalmic Inflamm Infect. 2021. PMID: 33586015 Free PMC article. No abstract available.

2

Comparison of combination therapy of prednisolone and cyclosporine with corticosteroid pulse therapy in Vogt-Koyanagi-Harada disease.

Ono T, Goto H, Sakai T, Nitta F, Mizuki N, Takase H, Kaneko Y, Hori J, Nakano S, Nao-I N, Ohguro N, Miyata K, Tomita M, Mochizuki M; Japan VKH Disease Treatment Study Group. Ono T, et al. Jpn J Ophthalmol. 2022 Mar;66(2):119-129. doi: 10.1007/s10384-021-00878-w. Epub 2021 Oct 24. Jpn J Ophthalmol. 2022. PMID: 34689288 Clinical Trial.

3

Diel rhythm of the inflammatory cytokine il1b in the Japanese medaka (Oryzias latipes) regulated by core components of the circadian clock.

Takeuchi T, Hata T, Miyanishi H, Yuasa T, Setoguchi S, Takeda A, Morimoto N, Hikima JI, Sakai M, Kono T. Takeuchi T, et al. Among authors: takeda a. Fish Shellfish Immunol. 2022 Aug;127:238-246. doi: 10.1016/j.fsi.2022.06.020. Epub 2022 Jun 17. Fish Shellfish Immunol. 2022. PMID: 35724845

4

Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension.

Shiratori N, Nishio Y, Takeda A, Sugimoto S, Takazawa K, Otsuka N, Ishida N, Shii D, Hori K, Nakamoto K. Shiratori N, et al. Among authors: takeda a. Clin Ophthalmol. 2021 Oct 4;15:3997-4003. doi: 10.2147/OPTH.S333042. eCollection 2021. Clin Ophthalmol. 2021. PMID: 34675468 Free PMC article.

5

Direct observation of Mn distribution/speciation within and surrounding a basidiomycete fungus in the production of Mn-oxides important in toxic element containment.

Takeda A, Oki T, Yokoo H, Kawamoto K, Nakano Y, Ochiai A, Winarni ID, Kitahara M, Miyoshi K, Fukuyama K, Ohara Y, Yamaji K, Ohnuki T, Hochella MF, Utsunomiya S. Takeda A, et al. Chemosphere. 2023 Feb;313:137526. doi: 10.1016/j.chemosphere.2022.137526. Epub 2022 Dec 10. Chemosphere. 2023. PMID: 36513194

6

Immunopathological Analysis of a Mouse Model of Arthritis-Associated Scleritis and Implications for Molecular Targeted Therapy for Severe Scleritis.

Nishio Y, Taniguchi H, Takeda A, Hori J. Nishio Y, et al. Among authors: takeda a. Int J Mol Sci. 2021 Dec 29;23(1):341. doi: 10.3390/ijms23010341. Int J Mol Sci. 2021. PMID: 35008766 Free PMC article.

7

The competing effects of microbially derived polymeric and low molecular-weight substances on the dispersibility of CeO₂ nanoparticles.

Nakano Y, Ochiai A, Kawamoto K, Takeda A, Ichiyoshi K, Ohnuki T, Hochella MF Jr, Utsunomiya S. Nakano Y, et al. Among authors: takeda a. Sci Rep. 2018 Feb 26;8(1):3648. doi: 10.1038/s41598-018-21976-9. Sci Rep. 2018. PMID: 29483563 Free PMC article.

8

A novel compound heterozygous mutation in the thyroglobulin gene resulting in congenital goitrous hypothyroidism with high serum triiodothyronine levels.

Kitanaka S, Takeda A, Sato U, Miki Y, Hishinuma A, Ieiri T, Igarashi T. Kitanaka S, et al. Among authors: takeda a. J Hum Genet. 2006;51(4):379-382. doi: 10.1007/s10038-006-0360-2. Epub 2006 Feb 14. J Hum Genet. 2006. PMID: 16477365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year